ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Addressing cardiovascular risk in type 2 diabetes - The LEADER trial
Event:
ESC CONGRESS 2016
Topic:
Diabetes management
Session type:
Satellite Symposium
Sponsored by Novo Nordisk
Date:
28 August 2016
Time:
18:30 - 20:00
Session
0
5
presentations
in this session
Introduction - Cardiovascular risk in diabetes and cardiovascular outcomes trials - Where do we come from?
Speaker:
Professor L. Ryden (Stockholm, SE)
Access
0
LEADER – Cardiovascular outcomes & the cardiologist’s perspective.
Speaker:
Professor S. Nissen (Cleveland, US)
Access
0
LEADER from the diabetologist’s perspective.
Speaker:
Professor J. Petrie (Glasgow, GB)
Access
0
Cardiovascular outcomes trials in diabetes – What have we learned?
Speaker:
Doctor M. Husain (Toronto, CA)
Access
0
Question and answers - Addressing cardiovascular risk in type 2 diabetes - The LEADER trial.
Speaker:
Professor L. Ryden (Stockholm, SE)
Access
0
5
speakers
from this session
Professor Lars Ryden
Department of medicine, Karolinska Institutet, Stockholm, Stockholm (Sweden)
31
presentations
0
follower
Professor Steven E Nissen
Cleveland Clinic Foundation, Cleveland (United States of America)
11
presentations
0
follower
Professor John R Petrie
, Glasgow (United Kingdom of Great Britain & Northern Ireland)
2
presentations
0
follower
Doctor Mansoor Husain
University of Toronto, Toronto (Canada)
7
presentations
1
follower
Professor Lars Ryden
Department of medicine, Karolinska Institutet, Stockholm, Stockholm (Sweden)
31
presentations
0
follower
This platform is supported by